Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Significantly Reduced Median Effective Dose (ED50) of Remimazolam for Anesthesia Induction in Frail Elderly Patients: A Prospective Dose-Finding Clinical Trial With Respiratory Volume Monitoring

NCT07467603 is registered in ClinicalTrials.gov with The First Hospital of Hebei Medical University as lead sponsor.

NCT NCT07467603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07467603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Significantly Reduced Median Effective Dose (ED50) of Remimazolam for Anesthesia Induction in Frail Elderly Patients: A Prospective Dose-Finding Clinical Trial With Respiratory Volume Monitoring
Lead sponsor
The First Hospital of Hebei Medical University
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2025
Completion date
April 30, 2025
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia induction, frailty